[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 11, Issue 1 (Winter 2022) ::
Shefaye Khatam 2022, 11(1): 105-118 Back to browse issues page
Alzheimer's Disease: Narrative Review of Clinical Symptoms, Molecular Alterations, and Effective Physical and Biophysical Methods in its Improvement
Parastoo Akbarabadi , Pouneh Sadat Pourhosseini *
Department of Biotechnology, Faculty of Biological Sciences, Al-Zahra University, Tehran, Iran , p.pourhosseini@alzahra.ac.ir
Abstract:   (927 Views)
Introduction: Alzheimer's disease is an irreversible neurodegenerative nervous disorder. Currently, both factors of amyloid-beta plaques and tau hyperphosphorylation, as well as the synergistic effects of these two factors, are leading changes in this disease. The researchers’ efforts to entirely cure the disease have not been successful because of the complexities of the pathophysiology of the disease. Furthermore, the blood-brain barrier is a serious challenge in delivering novel drugs. In recent years, different strategies have been developed to improve the cognitive skills of patients. Conclusion: Nowadays, the disappearance of the boundaries between different sciences has led to the development of new strategies which often offer non-invasive methods. These methods, such as biophysical interventions, improve the treatment of neurodegenerative diseases, such as Alzheimer's disease. This narrative review aims to describe some of these strategies and discuss their pros/cons over the traditional methods of drug consumption.
 
Keywords: Alzheimer Disease, Amyloid beta-Peptides, Biophysics
Full-Text [PDF 1034 kb]   (1312 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Neuropathology
References
1. Khaledi S, Ahmadi S. Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer's disease. Shefaye Khatam. 2016; 4(4): 67-88. [DOI:10.18869/acadpub.shefa.4.4.67]
2. Sayad A, Noruzinia M, Zamani M, Harirchian MH, Kazemnezhad A. LRP C766T polymorphism in Iranian patients with late-onset Alzheimer's Disease. Pathobiology Research. 2011; 14(3): 61-8.
3. Alzheimer's disease facts and figures. Alzheimer's & Dementia. 2020; 16(3): 391-460. [DOI:10.1002/alz.12068]
4. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO molecular medicine. 2016; 8(6): 595-608. [DOI:10.15252/emmm.201606210]
5. Zheng H, Koo EH. The amyloid precursor protein: beyond amyloid. Molecular neurodegeneration. 2006; 1(1): 1-12. [DOI:10.1186/1750-1326-1-5]
6. Cirrito JR, Kang J-E, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo. Neuron. 2008; 58(1): 42-51. [DOI:10.1016/j.neuron.2008.02.003]
7. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nature Reviews Neuroscience. 2007; 8(7): 499-509. [DOI:10.1038/nrn2168]
8. Mockett BG, Richter M, Abraham WC, Müller UC. Therapeutic potential of secreted amyloid precursor protein APPsα. Frontiers in molecular neuroscience. 2017; 10: 30. [DOI:10.3389/fnmol.2017.00030]
9. Uddin MS, Kabir MT. Emerging signal regulating potential of genistein against Alzheimer's disease: a promising molecule of interest. Frontiers in Cell and Developmental Biology. 2019; 7: 197. [DOI:10.3389/fcell.2019.00197]
10. O'brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annual review of neuroscience. 2011; 34: 185. [DOI:10.1146/annurev-neuro-061010-113613]
11. Bi X. Alzheimer disease: update on basic mechanisms. Journal of Osteopathic Medicine. 2010; 110(s98): 3-9.
12. Peric A, Annaert W. Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction? Acta neuropathologica. 2015; 129(3): 363-81. [DOI:10.1007/s00401-014-1379-7]
13. Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez F-J, Laurent C, Demeyer D, et al. Role of the Tau N-terminal region in microtubule stabilization revealed by newendogenous truncated forms. Scientific reports. 2015; 5(1): 1-10. [DOI:10.1038/srep09659]
14. Dorostkar MM, Zou C, Blazquez-Llorca L, Herms J. Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities. Acta neuropathologica. 2015; 130(1): 1-19. [DOI:10.1007/s00401-015-1449-5]
15. Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer's disease. Nature neuroscience. 2020; 23(10): 1183-93. [DOI:10.1038/s41593-020-0687-6]
16. Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nature Reviews Neurology. 2019; 15(9): 501-18. [DOI:10.1038/s41582-019-0228-7]
17. Pasand Mojdeh H, Alipour F, Borhani Haghighi M. Alzheimer's disease: Background, current and future aspects. The Neuroscience Journal of Shefaye Khatam. 2016; 4(3): 70-80. [DOI:10.18869/acadpub.shefa.4.3.70]
18. Martorell AJ, Paulson AL, Suk H-J, Abdurrob F, Drummond GT, Guan W, et al. Multi-sensory gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition. Cell. 2019; 177(2): 256-71. e22. [DOI:10.1016/j.cell.2019.02.014]
19. El Haj M, Postal V, Allain P. Music enhances autobiographical memory in mild Alzheimer's disease. Educational Gerontology. 2012; 38(1): 30-41. [DOI:10.1080/03601277.2010.515897]
20. Foster NA, Valentine ER. The effect of auditory stimulation on autobiographical recall in dementia. Experimental aging research. 2001; 27(3): 215-28. [DOI:10.1080/036107301300208664]
21. Irish M, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA, Robertson IH, et al. Investigating the enhancing effect of music on autobiographical memory in mild Alzheimer's disease. Dementia and geriatric cognitive disorders. 2006; 22(1): 108-20. [DOI:10.1159/000093487]
22. Liu X, Zuo H, Wang D, Peng R, Song T, Wang S, et al. Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer's disease rat model. PloS one. 2015; 10(5): e0126963. [DOI:10.1371/journal.pone.0126963]
23. Arendash GW. Review of the evidence that transcranial electromagnetic treatment will be a safe and effective therapeutic against Alzheimer's disease. Journal of Alzheimer's Disease. 2016; 53(3): 753-71. [DOI:10.3233/JAD-160165]
24. Tekieh E, Kazemi M, Tavakoli H, Saberi M, Ghanaati H, Hajinasrollah M, et al. The Effect of Extremely Low Frequency Electromagnetic Fields on Visual Learning, Memory and Anatomical Structures of the Brain in Male Rhesus Monkeys. ISMJ. 2018; 21(1): 40-53. [DOI:10.29252/ismj.21.1.40]
25. D'Arrigo JS. Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium. Advances in Colloid and Interface Science. 2018; 251: 44-54. [DOI:10.1016/j.cis.2017.12.002]
26. Gu X, Chen H, Gao X. Nanotherapeutic strategies for the treatment of Alzheimer's disease. Therapeutic Delivery. 2015; 6(2): 177-95. [DOI:10.4155/tde.14.97]
27. Liu G, Garrett MR, Men P, Zhu X, Perry G, Smith MA. Nanoparticle and other metal chelation therapeutics in Alzheimer disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2005; 1741(3): 246-52. [DOI:10.1016/j.bbadis.2005.06.006]



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbarabadi P, Pourhosseini P S. Alzheimer's Disease: Narrative Review of Clinical Symptoms, Molecular Alterations, and Effective Physical and Biophysical Methods in its Improvement. Shefaye Khatam 2022; 11 (1) :105-118
URL: http://shefayekhatam.ir/article-1-2332-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 1 (Winter 2022) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.06 seconds with 45 queries by YEKTAWEB 4645